US 11690853
Non-hormonal steroid modulators of NF-κβ for treatment of disease
granted A61KA61K31/57
Quick answer
US patent 11690853 (Non-hormonal steroid modulators of NF-κβ for treatment of disease) held by ReveraGen BioPharma, Inc. expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ReveraGen BioPharma, Inc.
- Grant date
- Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/57